Paper · 41990298

Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.

O'Connor TN and 8 others. JCO Precis Oncol, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study. Papers, record 41990298. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41990298

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.; PubMed
Journal: JCO Precis Oncol; PubMed
Year: 2026; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/41990298/; PubMed
DOI: https://doi.org/10.1200/po-25-01088; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13284841/; PubMed
The journal: https://conductscience.org/library/journal-index/101705370; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-08-13; PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	O'Connor TN	Thomas N	https://orcid.org/0000-0001-6965-0704
2	Schultz E	Emily	https://orcid.org/0000-0001-8591-0609
3	Horowitz M	Michael
4	Alexander MH	Margaret H	https://orcid.org/0000-0001-6992-5800
5	Fountzilas C	Christos
6	Cherkassky L	Leonid
7	Onel K	Kenan	https://orcid.org/0000-0002-2021-6250
8	Knudsen ES	Erik S	https://orcid.org/0000-0002-5130-5969
9	Witkiewicz AK	Agnieszka K

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Carcinoma, Pancreatic Ductal	Major topic
Pancreatic Neoplasms	Major topic
Genetic Testing	Major topic
Germ-Line Mutation	Major topic
Humans
Female
Male
Aged
Middle Aged

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
P30 CA016056	NCI NIH HHS	United States	P30CA016056	PubMed	NIH RePORTER
R01 CA247362	NCI NIH HHS	United States	R01CA247362	PubMed	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	19,806,144	Epidemiology of pancreatic cancer: an overview.	Nat Rev Gastroenterol Hepatol	2009	https://conductscience.org/library/papers/19806144	PubMed
2	38,781,545	Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers.	JCO Precis Oncol	2024	https://conductscience.org/library/papers/38781545	PubMed
3	36,549,838	Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care.	Clin Gastroenterol Hepatol	2023	https://conductscience.org/library/papers/36549838	PubMed
4	31,976,786	Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation.	J Clin Oncol	2020	https://conductscience.org/library/papers/31976786	PubMed
5	28,767,289	Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.	J Clin Oncol	2017	https://conductscience.org/library/papers/28767289	PubMed
6	27,215,758	The influence of marital status on the use of breast, cervical, and colorectal cancer screening.	Prev Med	2016	https://conductscience.org/library/papers/27215758	PubMed
7	35,704,792	The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.	J Clin Oncol	2022	https://conductscience.org/library/papers/35704792	PubMed
8	35,713,757	Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.	Fam Cancer	2023	https://conductscience.org/library/papers/35713757	PubMed
9	30,457,921	Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.	J Clin Oncol	2019	https://conductscience.org/library/papers/30457921	PubMed
10	35,988,957	Hereditary pancreatic cancer.	Best Pract Res Clin Gastroenterol	2022	https://conductscience.org/library/papers/35988957	PubMed

1 to 10 of 38

See all 38 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
MSH6	2,956	PubTator's text mining	https://conductscience.org/library/genes/2956

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41990298

GET https://conductscience.org/api/papers/v1/41990298/references?page=2

API reference For AI assistants